BCNU
Showing 1 - 25 of 189
Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma, Stage IV Choroidal and Ciliary Body Melanoma AJCC V8 Trial
Recruiting
- Metastatic Malignant Neoplasm in the Liver
- +2 more
- Carmustine
- +3 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson Univeristy
Nov 16, 2022
HIV, Lymphoma Trial in Zhanjiang (KL-7SHRNA injection solution)
Recruiting
- HIV Infections
- Lymphoma
- KL-7SHRNA injection solution
-
Zhanjiang, Guangdong, ChinaAffiliated hospital of Guangdong medical university
Jun 24, 2023
Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)
Recruiting
- Non-Hodgkin Lymphoma
- Hodgkin Lymphoma
- Etoposide
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jan 25, 2023
Primary CNS Lymphoma Trial in Moscow (Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide)
Recruiting
- Primary CNS Lymphoma
- Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide
-
Moscow, Russian FederationNathional Medical Research Center for Hematology
Jun 16, 2022
Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)
Recruiting
- Pancreatic Adenocarcinoma Metastatic
- +14 more
- Melphalan
- +5 more
-
Boston, Massachusetts
- +1 more
Dec 6, 2022
Oligodendroglioma; Oligoastrocytoma Trial in Marseille (Bis-Chloroethyl-Nitroso-Urea (BCNU) withTemozolomide)
Completed
- Oligodendroglioma; Oligoastrocytoma
- Bis-Chloroethyl-Nitroso-Urea (BCNU) withTemozolomide
-
Marseille, FranceAssistance Publique - Hôpitaux de Marseille
Feb 11, 2021
Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma Trial in Bethesda, Cleveland (biological,
Not yet recruiting
- Glioblastoma Multiforme
- +3 more
- P140K-MGMT
- +5 more
-
Bethesda, Maryland
- +1 more
Jul 4, 2022
Diffuse Large B Cell Lymphoma Trial in Saint Louis (Blinatumomab, Autologous stem cell transplant, Carmustine)
Active, not recruiting
- Diffuse Large B Cell Lymphoma
- Blinatumomab
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
May 4, 2022
Leukemia, Lymphoma, Non-Hodgkin, Hematologic Diseases Trial in Stanford (Sirolimus, MMF, BCNU)
Completed
- Leukemia
- +3 more
- Sirolimus
- +6 more
-
Stanford, CaliforniaStanford University School of Medicine
Sep 16, 2021
Recurrent Adult Hodgkin Lymphoma Trial in Duarte (biological, drug, other, procedure)
Active, not recruiting
- Recurrent Adult Hodgkin Lymphoma
- basiliximab
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Lymphoma, HIV Trial in United States (Autologous transplant, BCNU, Etoposide)
Completed
- Lymphoma
- HIV
- Autologous transplant
- +4 more
-
Duarte, California
- +15 more
Dec 6, 2022
Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)
Completed
- Glioblastoma
- Gliosarcoma
- 3-Dimensional Conformal Radiation Therapy
- +10 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 4, 2022
Diffuse Large Cell Lymphoma, Lymphoma Trial in Houston (Zevalin, Carmustine, Etoposide)
Completed
- Diffuse Large Cell Lymphoma
- Lymphoma
- Zevalin
- +6 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 12, 2021
Glioma Trial in Sacramento (bevacizumab, carmustine)
Completed
- Glioma
-
Sacramento, CaliforniaUniversity of California Davis Cancer Center
May 4, 2020
Glioma, Glioblastoma Multiforme, Astrocytoma Trial (Conventional RT, Hyperfractionated RT, Carmustine)
Completed
- Glioma
- +2 more
- Conventional RT
- +2 more
- (no location specified)
Nov 7, 2019
Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Basiliximab, Carmustine, Cytarabine)
Recruiting
- Recurrent Hodgkin Lymphoma
- Refractory Hodgkin Lymphoma
- Basiliximab
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 16, 2022
Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6
Withdrawn
- Recurrent Diffuse Large B-Cell Lymphoma
- +9 more
- Autologous Hematopoietic Stem Cell Transplantation
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 11, 2023
HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,
Recruiting
- HIV Infection
- +10 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
La Jolla, California
- +3 more
Dec 7, 2022
Glioblastoma Multiforme Trial in Cincinnati (BCNU Wafer, Irinotecan, Bevacizumab)
Withdrawn
- Glioblastoma Multiforme
- BCNU Wafer
- +2 more
-
Cincinnati, OhioUniversity of Cincinnati
Nov 21, 2019
Mantle Cell Lymphoma Trial in France (Obinutuzumab, Dexamethasone, Aracytine)
Active, not recruiting
- Mantle Cell Lymphoma
- Obinutuzumab
- +6 more
-
Amiens, France
- +29 more
Sep 14, 2021
Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,
Recruiting
- Autoimmune Disease
- +18 more
- Anti-Thymocyte Globulin
- +9 more
-
Denver, Colorado
- +2 more
Feb 1, 2023
Lymphoma, Leukemia Trial in Houston (drug, other, radiation, procedure)
Lymphoma, B-cell Lymphoma Trial in Houston (Leukapheresis, Stem Cell Transplant, CD19-specific T Cell Infusion)
Completed
- Lymphoma
- B-cell Lymphoma
- Leukapheresis
- +7 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 27, 2020
Hematopoietic Cell Transplantation Recipient, Recurrent DLBCL, Recurrent Grade 1 Follicular Lymphoma Trial in Columbus
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- +11 more
- Carmustine
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 29, 2021